The Olmesartan and amlodipine complex added adverse events, such as cholelithiasis
Cholelithiasis and dizziness were included in adverse events of the complex of Olmesartan and amlodipine.
On the 8th, the Ministry of Food and Drug Safety unveiled the revision instruction (bill) of approvals for the ‘olmesartan medoxomil·amlodipine besylate’ substance after the re-deliberation ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
